Adrenomedullin worsens skin necrosis in rats subjected to vincristine-induced extravasation

Clinical and Experimental Dermatology

Volumn 35, Issue 8, 2010, Pages 897-901

  Kesik, V ^a   Kurt, B ^a   Tunc, T ^a   Karslioglu, Y ^a   Citak, E C ^a   Kismet, E ^a   Koseoglu, V ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CARBONYL DERIVATIVE; GLUTATHIONE PEROXIDASE; HYALURONIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG EFFECT; DRUG EXTRAVASATION; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SCORING SYSTEM; SKIN BIOPSY; SKIN NECROSIS; SKIN ULCER; TISSUE INJURY; TISSUE LEVEL; WISTAR ALBINO GLAXO RAT;

ADRENOMEDULLIN; ALBINISM; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DISEASE MODELS, ANIMAL; GLUTATHIONE PEROXIDASE; HYALURONOGLUCOSAMINIDASE; MALE; MALONDIALDEHYDE; NECROSIS; RATS; RATS, WISTAR; SKIN; SKIN ULCER; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; VASODILATOR AGENTS; VINCRISTINE;

EID: 78149375893     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03803.x     Document Type: Article

References (13)

1. Ener RA, Meglathery SB, Styler M. Extravasation of systemic hemato-oncological therapies. Ann Oncol 2004; 15: 858-62.
2. Dorr RT, Alberts DS. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse. J Natl Cancer Inst 1985; 74: 113-20.
3. Disa JJ, Chang RR, Mucci SJ, Goldberg NH. Prevention of adriamycin-induced full-thickness skin loss using hyaluronidase infiltration. Plast Reconstr Surg 1998; 101: 370-4.
4. Eto T, Samson WK. Adrenomedullin and proadrenomedullin N-terminal 20 peptide: vasodilatory peptides with multiple cardiovascular and endocrine actions. Trends Endocrinol Metab 2001; 12: 91-3.
5. Hasbak P, Eskesen K, Lind H et al. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin. Basic Clin Pharmacol Toxicol 2006; 99: 162-7.
6. Dogru MI, Dogru AK, Gul M et al. The effect of adrenomedullin on rats exposed to lead. J Appl Toxicol 2008; 28: 140-6.
7. Durak I, Canbolat O, Kavutcu M et al. Activities of total, cytoplasmic, and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J Clin Lab Anal 1996; 10: 17-20.
8. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
9. Van Ye TM, Roza AM, Pieper GM et al. Inhibition of intestinal lipid peroxidation does not minimize morphologic damage. J Surg Res 1993; 55: 553-8.
10. Lowry OH, Rosebrough NJ, Farr AL et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
11. Levine RL, Garland D, Oliver CN et al. Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 1990; 186: 464-78.
12. Dorr RT. Antidotes to vesicant chemotherapy extravasations. Blood Rev 1990; 4: 41-60.
13. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000; 21: 138-67.